Form 8-K - Current report:
SEC Accession No. 0001193125-25-234001
Filing Date
2025-10-08
Accepted
2025-10-08 07:30:26
Documents
11
Period of Report
2025-10-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krro-20251007.htm   iXBRL 8-K 59227
2 EX-10.1 krro-ex10_1.htm EX-10.1 221595
  Complete submission text file 0001193125-25-234001.txt   434214

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krro-20251007.xsd EX-101.SCH 32946
14 EXTRACTED XBRL INSTANCE DOCUMENT krro-20251007_htm.xml XML 4949
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 251381232
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)